Canopy Growth Is Restating Two Years of Financials Before June 15 Earnings -- Here's What CGC Investors Need to Know Right Now
Canopy Growth is an important player in the marijuana sector. The stock is trading in penny-stock territory.
CGC - Canopy Growth Corporation
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$14.47
DETAILS
HIGH:
$27.85
LOW:
$8.00
MEDIAN:
$11.02
CONSENSUS:
$14.47
UPSIDE:
1291.35%
Stock News
Should You Buy CGC Stock After Marijuana Reclassification?
Canopy Growth gains attention as marijuana reclassification boosts cannabis sentiment, but margin pressure and execution risks persist.
Canopy Growth's Stock Just Dropped -- Here's Why I'm Still Not Buying
The company has struggled to improve its business -- and especially to earn a profit. It also has a habit of making dilutive secondary share issues.
Canopy Growth Corporation (CGC) Is a Trending Stock: Facts to Know Before Betting on It
Canopy Growth (CGC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Why Canopy Growth Corporation (CGC) Dipped More Than Broader Market Today
Canopy Growth Corporation (CGC) closed the most recent trading day at $0.98, moving 5.55% from the previous trading session.
Canopy Growth Provides Update on Financial Reporting and Announces Fourth Quarter and Fiscal Year 2026 Financial Results to be Presented on June 15, 2026
SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC) expects to release its financial results for the quarter and fiscal year ended March 31, 2026 before financial markets open on June 15, 2026. The Company also announced it plans to file restated financial results for the fiscal years ended March 31, 2025 and March 31, 2024 and to certain of the interim periods therein (the “Refiling”), in conjunction with its filing of.
Canadian Marijuana Stocks Showing Strong Momentum in May
Canadian cannabis stocks remain active in May 2026. Investors continue watching the sector for growth opportunities and reform catalysts. In addition, many traders expect future federal progress in the United States. That possibility has increased interest across the entire cannabis market. Recent headlines surrounding possible cannabis rescheduling also boosted momentum in leading names.
Canopy Growth Is One of the Market's Most Polarizing Stocks: 3 Scenarios for the Next 12 Months
Investors are no longer buying a hypergrowth cannabis stock. They're betting on a turnaround story.
Canopy Growth Corporation (CGC) Registers a Bigger Fall Than the Market: Important Facts to Note
Canopy Growth Corporation (CGC) closed at $1.1 in the latest trading session, marking a -1.79% move from the prior day.
Canopy Growth and Spectrum Therapeutics Expand Medical Portfolio with New 30 and 90-Pack Softgels and Enhanced Dosing Options
SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC) and Spectrum Therapeutics today announced an expansion of its Minor Cannabinoid softgel lineup, introducing new 30 and 90-pack formats and additional dosing options across its Optimized Spectrum portfolio. The expansion builds on the strong performance of existing 30-pack formats and reflects Canopy Growth's ongoing commitment to improving patient access through targete.
Investors Heavily Search Canopy Growth Corporation (CGC): Here is What You Need to Know
Recently, Zacks.com users have been paying close attention to Canopy Growth (CGC). This makes it worthwhile to examine what the stock has in store.
Canopy Growth Corporation (CGC) Beats Stock Market Upswing: What Investors Need to Know
Canopy Growth Corporation (CGC) reached $1.11 at the closing of the latest trading day, reflecting a +1.83% change compared to its last close.
Investing in Sin Stocks: High Returns From Unconventional Industries
Sin stocks attract investors for inelastic demand, steady cash flows, dividends and pricing power, often at lower valuations when excluded by ESG rules.
3 Canadian Marijuana Stocks That Could Benefit From U.S. Reform
The Canadian cannabis sector continues to evolve as investors look for the next major catalyst. Recently, optimism has increased around potential U.S. cannabis reform. As a result, many Canadian companies could benefit from future expansion opportunities. Additionally, these companies already trade on major exchanges, giving them broader access to investors. However, volatility still remains across the sector. Therefore, using technical analysis and managing risk is critical when trading these stocks.
Canopy Growth Stock Is Jumping. Is It Overdue for a Much Bigger Rally?
The pot stock is up over 30% in just the past month.
Canopy Growth Corporation (CGC) Stock Sinks As Market Gains: What You Should Know
Canopy Growth Corporation (CGC) concluded the recent trading session at $1.19, signifying a -2.87% move from its prior day's close.
Canopy Growth Is Rallying Again. But Is It a Dead Cat Bounce?
Canopy Growth is a penny stock, so small price movements can lead to huge percentage changes. The marijuana company recently bought another company, extending its reach in medical marijuana.
Stock Market Today (LIVE): Meta Plugs Into Amazon's AI Chips; Intel Soars 25% on Earnings
Top insights from the latest market news from Friday, April 24, from The Motley Fool analysts on Team Rule Breakers and Team Hidden Gems.
Breakfast News: Intel CEO Tan Touts Rosy AI Future
Intel results show strong AI demand, cannabis stocks slump after DOJ ruling, and more
Cannabis Stocks Soared—Than Sank. Here's What Investors Need to Know.
Marijuana-related investments were flying high this morning. Then they reversed course, and quickly.
Price Targets
Canopy Growth price target lowered to C$11 from C$18 at Alliance Global Partners
$11.00
(was $8.21)
Aaron Grey
·
Alliance Global Partners
Canopy Growth initiated with an Underweight at Wells Fargo
$8.00
(was $10.15)
Derek Archila
·
Wells Fargo
Jefferies Keeps a Hold Rating on Canopy Growth (CGC)
$16.70
(was $11.62)
Owen Bennett
·
Jefferies
Canopy Growth price target lowered to C$35 from C$55 at Desjardins
$35.00
(was $25.27)
John Chu
·
Desjardins